Doug Schenkel
Stock Analyst at Wolfe Research
(2.84)
# 1,568
Out of 5,169 analysts
70
Total ratings
50%
Success rate
31.38%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Upgrades: Outperform | $60 | $33.74 | +77.83% | 3 | Dec 10, 2025 | |
| WAT Waters | Upgrades: Outperform | $480 | $296.99 | +61.62% | 2 | Dec 10, 2025 | |
| GH Guardant Health | Upgrades: Outperform | $75 | $88.75 | -15.49% | 3 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Initiates: Outperform | $32 | $18.54 | +72.60% | 1 | Jul 14, 2025 | |
| TEM Tempus AI | Initiates: Outperform | $60 | $50.84 | +18.02% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $75.05 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $47.28 | +26.90% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $15.40 | +81.82% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $239.42 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $119.27 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $3.12 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $285 | $195.21 | +46.00% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $112.75 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $49 | $41.54 | +18.08% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $18.09 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $120.84 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $103.94 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $472.71 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.78 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $87.37 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.38 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $7.80 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $198.38 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.00 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $3.03 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.01 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.22 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.78 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $18.55 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $1.47 | +1,124.49% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $23.91 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $230.49 | -60.95% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.72 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $153.95 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $67.32 | -76.23% | 2 | Sep 28, 2017 |
Bruker
Dec 10, 2025
Upgrades: Outperform
Price Target: $60
Current: $33.74
Upside: +77.83%
Waters
Dec 10, 2025
Upgrades: Outperform
Price Target: $480
Current: $296.99
Upside: +61.62%
Guardant Health
Sep 25, 2025
Upgrades: Outperform
Price Target: $75
Current: $88.75
Upside: -15.49%
Caris Life Sciences
Jul 14, 2025
Initiates: Outperform
Price Target: $32
Current: $18.54
Upside: +72.60%
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $50.84
Upside: +18.02%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $75.05
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $47.28
Upside: +26.90%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $15.40
Upside: +81.82%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $239.42
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $119.27
Upside: -
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $3.12
Upside: -
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $195.21
Upside: +46.00%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $112.75
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $49
Current: $41.54
Upside: +18.08%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $18.09
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $120.84
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $103.94
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $472.71
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $4.78
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $87.37
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.38
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $7.80
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $198.38
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.00
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $3.03
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.01
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.22
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.78
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $18.55
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $1.47
Upside: +1,124.49%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $23.91
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $230.49
Upside: -60.95%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $4.72
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $153.95
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $67.32
Upside: -76.23%